VIVUS, Inc.
(NASDAQ : VVUS)

( )
VVUS PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Loading VVUS News...
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
SHPGShire PLC Sponsored ADR
-0.84%164.649.9%$639.58m
VRXValeant Pharmaceuticals International, Inc.
-7.60%18.737.1%$551.37m
PRGOPerrigo Co. Plc
-3.58%87.754.0%$252.68m
JAZZJazz Pharmaceuticals Plc
-3.87%132.572.7%$123.80m
ENDPEndo International Plc
-7.81%13.694.1%$122.15m
MNKMallinckrodt Plc
-3.41%54.0611.7%$86.39m
ICPTIntercept Pharmaceuticals, Inc.
-8.57%130.6713.8%$84.91m
HZNPHorizon Pharma plc
-7.51%15.039.7%$62.98m
UTHRUnited Therapeutics Corporation
-3.70%98.3319.5%$61.42m
GWPHGW Pharmaceuticals PLC Sponsored ADR
6.69%88.8812.2%$56.32m
RLYPRelypsa, Inc.
-8.84%15.8933.0%$55.86m
MDCOMedicines Company
0.06%33.2819.6%$51.18m
CTLTCatalent Inc
-6.49%21.314.1%$46.81m
ICLRICON Plc
-2.81%65.723.3%$36.19m
PCRXPacira Pharmaceuticals, Inc.
-2.24%37.9818.5%$29.12m

Company Profile

VIVUS, Inc. operates as a biopharmaceutical company, which develops innovative, next-generation therapies to address unmet needs in obesity, diabetes, sleep apnea and sexual health. The company's products include Qsymia Obesity, Qsymia Sleep Apnea, Qsymia Diabetes and Avanafil. VIVUS was founded by Virgil A. Place on April 16, 1991 and is headquartered in Mountain View, CA.